Mon Dec 01, 2003
Who is Maya Leabman?
Maya Leabman is a postdoctoral fellow who is both developing a pharmacogenetics consortium between the School and industry and conducting her own research in pharmacogenetics. She works with Kathy Giacomini, chair, Department of Biopharmaceutical Sciences.
Wed Nov 12, 2003
R. William Soller, PhD is the new director of the Center for Consumer Self Care, UCSF School of Pharmacy. The Center supports research on consumer behavior and health policy issues related to prescription and non-prescription medicines and dietary supplements. For more information, see New Leader for Center for Consumer Self Care at UCSF and School of Pharmacy [Center for Consumer Self Care] [link defunct].
Wed Oct 29, 2003
The California Poison Control System (CPCS), a unit of the School of Pharmacy, Department of Clinical Pharmacy at the University of California, San Francisco in conjunction with the California's Statewide Area Health Education Center Program (AHEC) has been awarded a US$1.5 million federal grant to help prepare California health professionals to rapidly and effectively respond to bioterrorism and other public health emergencies.
Mon Sep 01, 2003
Who is Nobuhisa Shimba?
Nobuhisa Shimba is a visiting scientist working in Charles Craik’s Department of Pharmaceutical Chemistry lab at Mission Bay. Each of the three School of Pharmacy departments welcome visiting scholars from industry or other educational institutions for varying lengths of time. Nobu comes to us from the Ajinomoto Company, Kawasaki, Japan. He grew up in Shizuoka, located between Tokyo and Osaka, the home of Mt. Fuji.
Fri Aug 29, 2003
Michael Winter, PharmD, professor of clinical pharmacy, School of Pharmacy, University of California, San Francisco (UCSF) is the California Society of Health-System Pharmacists (CSHP) 2003 Pharmacist of the Year. The award, one of CSHP's highest honors, will be presented on October 24, 2003 during the society's annual meeting in Sacramento, California.
Wed Jul 09, 2003
The UCSF School of Pharmacy will establish its first distinguished professorship following a gift from one of its most illustrious alums. Harry Wm. Hind—inventor of both the Lidoderm® patch and the wetting solution that helped bring contact lenses into widespread use—and his wife, Diana V. Hind, have given US$2.65 million to establish the Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Science.
Tue Jul 01, 2003
Reactions to Mission Bay moves. Ideas for generating revenue to offset the California budget deficit. How we gather input and advice to shape our planning. Awards and retirements (Kuntz, McCart, Ruggiero, Sutherland). Relocation of the Office of Student and Curricular Affairs. New School of Medicine Dean David Kessler, MD. Harry W. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences.
Thu Mar 06, 2003
A plan seeded in 1996 by the World Health Organization for an international agreement, [Framework Convention on Tobacco Control] [link defunct]," is undergoing final discussions by member states before submission to the World Health Assembly in May. The plan outlines a global regulatory system aimed at controlling the tobacco pandemic, which, if no action is taken, is expected to claim an estimated 10 million lives by the late 2020s.
Thu Mar 06, 2003
UCSF faculty members voted last December 52% to 48% to no longer accept funds from manufacturers of tobacco products or their subsidiaries. Those in favor of the ban argued that UCSF must oppose tobacco industry funding of academia since the health sciences campus is a leader in tobacco control policies and the fight against nicotine addiction and tobacco use prevention. Those opposed to the ban argued that the issue is one of academic freedom in choosing funding sources.
Mon Feb 03, 2003
California budget deficit leads to UC cuts and student fee increases. Scientists move in to Mission Bay. 2003 PharmD applications up 32% over 2002. ACPE Accreditation approved. Exit survey and post-graduate survey results. Honors and awards (The Annals of Pharmacotherapy, Kuntz, Pohorille, Nguyen, Whitely).
Thu Jan 02, 2003
The tobacco industry was the silent partner behind a study to refute an influential 1981 Japanese research study about the harmful effects of passive smoke, according to UCSF School of Pharmacy tobacco policy scientist Lisa Bero, PhD and her colleague Mi-Kyung Hong, MPH. For more information, see "How the tobacco industry responded to an influential study of the health effects of secondhand smoke,"
Thu Jan 02, 2003
Two studies conducted by UCSF School of Pharmacy researchers demonstrate how follow-up care by pharmacists can help patients adhere to their medications, decrease the number of return visits, and increase patient satisfaction. For more information, see UCSF Magazine, "L is for Listening," August 2002.